-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
We lower our target to $96 from $150, 12.9x our 2027 EPS estimate, a discount to ZTS's 10-year historical forward P/E average. We cut our 2026 EPS view to $6.92 from $7.03. We keep our 2027 EPS forecast at $7.43. Shares of ZTS are down more than 21% today after the company missed estimates, recording flat organic growth Y/Y, while guidance for the full 2026 for both revenue ($9.680B-$9.960B, 2%-5% organic operational growth) and adjusted EPS ($6.85-$7.00) was cut above expectations, which, in our view, signals that the challenging first quarter environment is likely to persist. The Q1 performance showed significant segment divergence: International business grew 10% organically, while the U.S. segment declined 8%. The Livestock division showed robust 12% organic growth, contrasting with a 4% operational decline in Companion Animal. The U.S. segment saw an 8% revenue decline, with companion animal down 11% due to pet owner price sensitivity, aggressive competitor pricing, and lack of market expansion.